From: Serum miR-34a as a potential biomarker for diagnosis of inflammatory bowel diseases in Egyptian patients
Parameter
IBD (n=37)
p
miR-34a
Median
0.69
<0.01(a)**
Mean rank
19.27
Positivity rate “n of cases≤1.36 (%)”
36 (97.3%)
<0.01(b)**
MACF1
3.23
33.00
Positivity rate “n of cases≥1.2 (%)”
37 (100%)